Research Paper Volume 13, Issue 6 pp 8276—8289

Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma

Construction and validation of a predictive nomogram. (A) Nomogram for predicting 1-, 3-, and 5-year OS of KIRC patients in the TCGA cohort. (B) DCA showing that the nomogram confers higher net benefit to predict OS when the threshold probability is larger than 3%. (C–E) Calibration curves indicating the performance of the nomogram in predicting 1-, 3- and 5-year OS compared to an ideal model.

Figure 6. Construction and validation of a predictive nomogram. (A) Nomogram for predicting 1-, 3-, and 5-year OS of KIRC patients in the TCGA cohort. (B) DCA showing that the nomogram confers higher net benefit to predict OS when the threshold probability is larger than 3%. (CE) Calibration curves indicating the performance of the nomogram in predicting 1-, 3- and 5-year OS compared to an ideal model.